Explore the latest in pemphigus, including recent advances in understanding the etiology, diagnosis, and management of the condition.
This cross-sectional analysis using Explorys data examines the prevalence of pemphigus in US adults across age, sex, and race groups.
This case report describes the occurrence of a decrease of anti-DSG3, but not anti-DSG1, after cessation of sitagliptin treatment in a patient with pemphigus vulgaris.
This cross-sectional study estimates the association between pemphigus and a wide range of nonhematologic malignancies by examining a large cohort of patients with pemphigus.
This case-series study of 11 patients with severe, difficult-to-treat pemphigus examines whether rituximab alone can be used long-term as maintenance therapy for prevention of relapse.
This case series presents 3 cases of patients with Hailey-Hailey disease demonstrating varying responses to naltrexone.
This population-based cross-sectional study estimates the association between pemphigus and 4 neurologic conditions using one of the largest cohorts of patients with pemphigus.
This case series evaluates whether low-dose naltrexone is efficacious and safe in the treatment of recalcitrant familial benign pemphigus (Hailey-Hailey disease).
This case series investigates whether low-dose naltrexone is an effective treatment for recalcitrant Hailey-Hailey disease.
This case report describes esophagitis dissecans superficialis endoscopically induced in a patient with pemphigus vulgaris and gastrointestinal complaints.
This study examines the incidence of and risk factors for hospitalization for patients with pemphigus and cost of care.
A 64-year-old African American woman presented with crusted scalp plaques, erosive stomatitis, and multiple bullae, erosions, and hyperpigmented patches on her trunk and extremities. Her serum creatinine level was 7.1 mg/dL; a complete blood cell count was unremarkable. What would you do next?
A woman in her 40s with a medical history of pulmonary embolism and deep venous thrombosis presented with a 6-month history of pruritic, pink scaling plaques on her face and neck with subsequent lesions on the chest, abdomen, and back that flared with sun exposure. What is your diagnosis?
In this case series evaluating intralesional rituximab injections for pemphigus vulgaris in 3 patients, the treatment had no adverse effects, reduced the amount of drug administered, and was less expensive than intravenous administration.
This case describes opportunistic infection with Trichosporon inkin refractory to conventional antifungal treatment.
This case series suggests the use of a combination of rituximab and topical corticosteroids in the treatment of pemphigus vulgaris.
Nakahara et al describe a patient with pemphigus vulgaris in remission, who had a high enzyme-linked immunosorbent assay (ELISA) index for anti–desmoglein 3 antibody while the indirect immunofluorescence (IIF) result was negative. The authors report this case focusing on the discrepancy between ELISA and IIF findings, as well as on the specific characteristics of the patient’s autoantibodies evaluated by newly developed methods.
Ellebrecht et al describe the use of veltuzumab, a second-generation humanized anti-CD20 antibody, in a patient with pemphigus vulgaris.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: